Effect of combined treatment with zoledronic acid and parathyroid hormone on mouse bone callus structure and composition.

[1]  B. Cortet,et al.  Doses effects of zoledronic acid on mineral apatite and collagen quality of newly-formed bone in the rat's calvaria defect. , 2016, Bone.

[2]  A. Schindeler,et al.  Maximizing bone formation in posterior spine fusion using rhBMP‐2 and zoledronic acid in wild type and NF1 deficient mice , 2014, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[3]  P. Schneider,et al.  Quantitative phenotyping of bone fracture repair: a review. , 2014, BoneKEy reports.

[4]  R Müller,et al.  Altered lacunar and vascular porosity in osteogenesis imperfecta mouse bone as revealed by synchrotron tomography contributes to bone fragility. , 2014, Bone.

[5]  S. Goldstein,et al.  Fracture healing with alendronate treatment in the Brtl/+ mouse model of osteogenesis imperfecta. , 2013, Bone.

[6]  R. Ritchie,et al.  Proposed Pathogenesis for Atypical Femoral Fractures: Lessons from Materials Research , 2022 .

[7]  G. Duda,et al.  Microstructure and homogeneity of distribution of mineralised struts determine callus strength. , 2013, European cells & materials.

[8]  Hang Lee,et al.  Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial , 2013, The Lancet.

[9]  T. Keaveny,et al.  Hip and spine strength effects of adding versus switching to teriparatide in postmenopausal women with osteoporosis treated with prior alendronate or raloxifene , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  Alexander J. Makowski,et al.  Polarization control of Raman spectroscopy optimizes the assessment of bone tissue. , 2013, Journal of biomedical optics.

[11]  S. Majumdar,et al.  Postmenopausal women treated with combination parathyroid hormone (1–84) and ibandronate demonstrate different microstructural changes at the radius vs. tibia: the PTH and Ibandronate Combination Study (PICS) , 2013, Osteoporosis International.

[12]  X. S. Liu,et al.  A closer look at the immediate trabecula response to combined parathyroid hormone and alendronate treatment. , 2013, Bone.

[13]  H. Resch,et al.  Antiresorptives overlapping ongoing teriparatide treatment result in additional increases in bone mineral density , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  J. Wysolmerski.  Osteocytic osteolysis: time for a second look? , 2012, BoneKEy reports.

[15]  E. Luo,et al.  The effects of combined human parathyroid hormone (1-34) and zoledronic acid treatment on fracture healing in osteoporotic rats , 2012, Osteoporosis International.

[16]  Stefan Judex,et al.  Changes in intracortical microporosities induced by pharmaceutical treatment of osteoporosis as detected by high resolution micro-CT. , 2012, Bone.

[17]  D-Y Kim,et al.  Short-term teriparatide therapy as an adjunctive modality for bisphosphonate-related osteonecrosis of the jaws , 2012, Osteoporosis International.

[18]  W. Lems,et al.  Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational Study , 2012, European journal of endocrinology.

[19]  G H van Lenthe,et al.  The importance of murine cortical bone microstructure for microcrack initiation and propagation. , 2011, Bone.

[20]  Michael D Morris,et al.  Raman Assessment of Bone Quality , 2011, Clinical orthopaedics and related research.

[21]  T. Einhorn,et al.  Anabolic Agents and Bone Quality , 2011, Clinical orthopaedics and related research.

[22]  J. Wilkinson,et al.  Bisphosphonates in orthopedic applications. , 2011, Bone.

[23]  S. Boonen,et al.  Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1–34)] in postmenopausal osteoporosis , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  F. Frassica,et al.  Inhibition of Sca-1-positive skeletal stem cell recruitment by alendronate blunts the anabolic effects of parathyroid hormone on bone remodeling. , 2010, Cell stem cell.

[25]  Ralph Müller,et al.  Quantitative, structural, and image-based mechanical analysis of nonunion fracture repaired by genetically engineered mesenchymal stem cells. , 2010, Journal of biomechanics.

[26]  Sonja Gamsjaeger,et al.  Cortical bone composition and orientation as a function of animal and tissue age in mice by Raman spectroscopy. , 2010, Bone.

[27]  Ralph Müller,et al.  Guidelines for assessment of bone microstructure in rodents using micro–computed tomography , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  E. Fisher,et al.  Anabolic and Antiresorptive Drugs Improve Trabecular Microarchitecture and Reduce Fracture Risk following Radiation Therapy , 2010, Calcified Tissue International.

[29]  Hang Lee,et al.  Effects of teriparatide, alendronate, or both in women with postmenopausal osteoporosis. , 2010, The Journal of clinical endocrinology and metabolism.

[30]  I. Hvid,et al.  Three-dimensional microstructural properties of regenerated mineralizing tissue after PTH (1-34) treatment in a rabbit tibial lengthening model. , 2009, Journal of musculoskeletal & neuronal interactions.

[31]  A. Abou-Samra,et al.  PTH and PTHrP signaling in osteoblasts. , 2009, Cellular signalling.

[32]  Richard M Aspden,et al.  A comparison of cortical and trabecular bone from C57 Black 6 mice using Raman spectroscopy. , 2009, Bone.

[33]  Thomas A Einhorn,et al.  Micro-computed tomography assessment of fracture healing: relationships among callus structure, composition, and mechanical function. , 2009, Bone.

[34]  P. Roberson,et al.  Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts. , 2009, Bone.

[35]  Tamara Sztynda,et al.  Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling. , 2008, Bone.

[36]  D. Goltzman.  Studies on the mechanisms of the skeletal anabolic action of endogenous and exogenous parathyroid hormone. , 2008, Archives of biochemistry and biophysics.

[37]  P. Aspenberg,et al.  Additive effects of PTH and bisphosphonates on the bone healing response to metaphyseal implants in rats , 2008, Acta orthopaedica.

[38]  Hiroshi Tanaka,et al.  Sequential Treatment with Intermittent Low-Dose Human Parathyroid Hormone (1-34) and Bisphosphonate Enhances Large-Size Skeletal Reconstruction by Vascularized Bone Transplantation , 2007, Calcified Tissue International.

[39]  S. Cummings,et al.  Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. , 2007, The New England journal of medicine.

[40]  William F. Finney,et al.  Bone tissue compositional differences in women with and without osteoporotic fracture. , 2006, Bone.

[41]  Mitsuhiko Takahashi,et al.  Bisphosphonate modulates morphological and mechanical properties in distraction osteogenesis through inhibition of bone resorption. , 2006, Bone.

[42]  A. Schindeler,et al.  Osteoclasts but not osteoblasts are affected by a calcified surface treated with zoledronic acid in vitro. , 2005, Biochemical and biophysical research communications.

[43]  R. Müller,et al.  Compartmental Bone Morphometry in the Mouse Femur: Reproducibility and Resolution Dependence of Microtomographic Measurements , 2005, Calcified Tissue International.

[44]  R. Lindsay,et al.  Daily and cyclic parathyroid hormone in women receiving alendronate. , 2005, The New England journal of medicine.

[45]  L. Claes,et al.  Prediction of fracture callus mechanical properties using micro-CT images and voxel-based finite element analysis. , 2005, Bone.

[46]  C. Hernandez,et al.  Osteocyte density in woven bone. , 2004, Bone.

[47]  H. Ozawa,et al.  Osteocytic osteolysis observed in rats to which parathyroid hormone was continuously administered , 2004, Journal of Bone and Mineral Metabolism.

[48]  P. Aspenberg,et al.  Intermittent parathyroid hormone (1–34) enhances mechanical strength and density of new bone after distraction osteogenesis in rats , 2004, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[49]  L. Qin,et al.  Parathyroid hormone: a double-edged sword for bone metabolism , 2004, Trends in Endocrinology & Metabolism.

[50]  J. Finkelstein,et al.  The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. , 2003, The New England journal of medicine.

[51]  Mary L Bouxsein,et al.  The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. , 2003, The New England journal of medicine.

[52]  Jacques P. Brown,et al.  Intravenous zoledronic acid in postmenopausal women with low bone mineral density. , 2002, The New England journal of medicine.

[53]  D. Vashishth,et al.  Estimation of bone matrix apparent stiffness variation caused by osteocyte lacunar size and density. , 2001, Journal of biomechanical engineering.

[54]  Y. Hirasawa,et al.  Development of bone canaliculi during bone repair. , 2000, Bone.

[55]  G. Reilly,et al.  Observations of microdamage around osteocyte lacunae in bone. , 2000, Journal of biomechanics.

[56]  X. D. Zhu,et al.  Microstructural evolution in external callus of human long bone , 2000 .

[57]  Michael D. Morris,et al.  Chemical Microstructure of Cortical Bone Probed by Raman Transects , 1999 .

[58]  C. Rey,et al.  MicroRaman Spectral Study of the PO4 and CO3 Vibrational Modes in Synthetic and Biological Apatites , 1998, Calcified Tissue International.

[59]  G. Rodan,et al.  Bisphosphonates: mechanisms of action , 1998, Endocrine reviews.

[60]  X. D. Zhu,et al.  Microstructural investigation of the early external callus after diaphyseal fractures of human long bone. , 1995, Journal of structural biology.

[61]  O. J. Dunn.  Multiple Comparisons Using Rank Sums , 1964 .

[62]  L. Gerstenfeld,et al.  Overview of skeletal repair (fracture healing and its assessment). , 2014, Methods in molecular biology.

[63]  Anna Teti,et al.  Do osteocytes contribute to bone mineral homeostasis? Osteocytic osteolysis revisited. , 2009, Bone.